Related Experiment Video
Updated: Jun 29, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Newborn screening: what pediatricians should know
Letícia Lima Leão1, Marcos José Burle de Aguiar
1Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Jornal De Pediatria
|December 4, 2008
Summary
Neonatal screening programs vary globally, with Brazil screening for four core conditions. Pediatricians play a vital role in these essential public health initiatives, despite ongoing ethical and financial discussions regarding expanded screening panels.
Area of Science:
- Public Health
- Pediatrics
- Genetics
Background:
- Neonatal screening is a critical public health strategy for early detection and prevention of pediatric diseases.
- Significant global diversity exists in the scope and implementation of neonatal screening programs.
- The role of pediatricians in neonatal screening requires clear definition within public health frameworks.
Purpose of the Study:
- To review the global landscape of neonatal screening.
- To assess the current status of neonatal screening in Brazil.
- To delineate the responsibilities of pediatricians in neonatal screening programs.
Main Methods:
- Comprehensive literature review of scientific articles from MEDLINE, Cochrane, PubMed, and MD Consult (1998-2007).
- Inclusion of medical textbooks on genetics and inborn errors of metabolism.
- Analysis of Brazilian National Neonatal Screening Program standards and Ministry of Health decrees.
Main Results:
- International neonatal screening programs vary widely in the number of diseases targeted.
- Brazil's National Neonatal Screening Program (established 2001) screens for phenylketonuria, congenital hypothyroidism, sickle-cell anemia, and cystic fibrosis.
- Expanding screening panels, particularly using mass spectrometry, faces financial and ethical debates.
Conclusions:
- Neonatal screening represents a major advancement in preventing pediatric diseases.
- Effective implementation requires multidisciplinary collaboration and robust public health policies.
- Consensus on optimal screening panels remains elusive, necessitating further scientific and ethical deliberation.
- Pediatricians are integral to all phases of neonatal screening programs.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:30Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include: